Characteristics of the MolNE patient group
| . | Patients (N = 178) . | |
|---|---|---|
| Characteristics . | No. . | % . |
| Age, y | ||
| Median (range) | 29 (15-64) | |
| ≤35 y | 112 | 63 |
| >5 y | 66 | 37 |
| Risk stratification | ||
| Standard risk | 131 | 74 |
| High risk | 47 | 26 |
| Immunophenotype | ||
| C-/pre-B-ALL | 111 | 62 |
| Pro-B-ALL | 11 | 6 |
| Early-T-ALL | 7 | 4 |
| Mature T-ALL | 7 | 4 |
| Thymic-T-ALL | 42 | 24 |
| White blood cell count, /µL | ||
| Median (range) | 11400 (400-463900) | |
| . | Patients (N = 178) . | |
|---|---|---|
| Characteristics . | No. . | % . |
| Age, y | ||
| Median (range) | 29 (15-64) | |
| ≤35 y | 112 | 63 |
| >5 y | 66 | 37 |
| Risk stratification | ||
| Standard risk | 131 | 74 |
| High risk | 47 | 26 |
| Immunophenotype | ||
| C-/pre-B-ALL | 111 | 62 |
| Pro-B-ALL | 11 | 6 |
| Early-T-ALL | 7 | 4 |
| Mature T-ALL | 7 | 4 |
| Thymic-T-ALL | 42 | 24 |
| White blood cell count, /µL | ||
| Median (range) | 11400 (400-463900) | |
B-ALL, B-cell acute lymphoblastic leukemia; T-ALL, T-cell acute lymphoblastic leukemia.